On Friday, Exact Sciences Corp (NASDAQ: EXAS) was -0.24% drop from the session before settling in for the closing price of $62.61. A 52-week range for EXAS has been $40.62 – $79.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 43.88% over the past five years. When this article was written, the company’s average yearly earnings per share was at -7.25%. With a float of $182.38 million, this company’s outstanding shares have now reached $185.05 million.
Let’s look at the performance matrix of the company that is accounted for 6600 employees. In terms of profitability, gross margin is 72.1%, operating margin of -8.76%, and the pretax margin is -7.82%.
Exact Sciences Corp (EXAS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Exact Sciences Corp stocks. The insider ownership of Exact Sciences Corp is 1.46%, while institutional ownership is 99.84%. The most recent insider transaction that took place on Nov 13 ’24, was worth 1,001,325. In this transaction President and CEO of this company bought 19,500 shares at a rate of $51.35, taking the stock ownership to the 1,074,191 shares. Before that another transaction happened on Oct 08 ’24, when Company’s EVP, GM, Precision Oncology sold 929 for $70.00, making the entire transaction worth $65,030. This insider now owns 12,758 shares in total.
Exact Sciences Corp (EXAS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.25% per share during the next fiscal year.
Exact Sciences Corp (NASDAQ: EXAS) Trading Performance Indicators
You can see what Exact Sciences Corp (EXAS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.28. Likewise, its price to free cash flow for the trailing twelve months is 117.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Exact Sciences Corp (EXAS)
Exact Sciences Corp (NASDAQ: EXAS) saw its 5-day average volume 2.23 million, a negative change from its year-to-date volume of 2.64 million. As of the previous 9 days, the stock’s Stochastic %D was 86.42%. Additionally, its Average True Range was 2.86.
During the past 100 days, Exact Sciences Corp’s (EXAS) raw stochastic average was set at 64.44%, which indicates a significant decrease from 85.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.77% in the past 14 days, which was lower than the 71.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $63.36, while its 200-day Moving Average is $58.12. Nevertheless, the first resistance level for the watch stands at $63.77 in the near term. At $65.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $65.84. If the price goes on to break the first support level at $61.70, it is likely to go to the next support level at $60.94. The third support level lies at $59.64 if the price breaches the second support level.
Exact Sciences Corp (NASDAQ: EXAS) Key Stats
There are 185,076K outstanding shares of the company, which has a market capitalization of 11.53 billion. As of now, sales total 2,500 M while income totals -204,150 K. Its latest quarter income was 708,660 K while its last quarter net income were -38,240 K.
